ARTICLE | Distillery Therapeutics
Neurology
December 4, 2018 1:28 PM UTC
In vitro and mouse studies identified an inhibitor of Aβ42 polymerization that could help treat AD. In vitro screening of nine amyloid-binding compounds in polymerization assays, followed by in vitro ...
BCIQ Company Profiles